# Effect of Ezetimibe Plus Simvastatin on Flow-Mediated Brachial Artery Vasoactivity in Subjects With Primary Hypercholesterolemia (Study P03336)

> **NCT00651391** · PHASE3 · TERMINATED · sponsor: **Organon and Co** · enrollment: 28 (actual)

## Conditions studied

- Hypercholesterolemia
- Atherosclerosis

## Interventions

- **DRUG:** Ezetimibe + Simvastatin
- **DRUG:** Simvastatin
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT00651391
- **Lead sponsor:** Organon and Co
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2003-10-01
- **Primary completion:** 2004-09-01
- **Final completion:** 2004-09-01
- **Target enrollment:** 28 (ACTUAL)
- **Why stopped:** Slow enrollment
- **Last updated:** 2024-08-15

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00651391

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00651391, "Effect of Ezetimibe Plus Simvastatin on Flow-Mediated Brachial Artery Vasoactivity in Subjects With Primary Hypercholesterolemia (Study P03336)". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT00651391. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*